WaferGen Biosystems, Inc. is a leader in the development of state-of-the-art genetic analysis systems for the life science and pharmaceutical industries. It is in the early stages of commercializing its product.

The Company has successfully developed the SmartChip System, a nano-scale version of a “gold standard” genetic analysis technique – qPCR. This instrument has important advantages vs. competitive systems:

• Simplified work flow
• Fast time to results
• Significant cost benefits
• Content and format flexibility

Based on collaborations established with leading research institutions, WaferGen believes that the SmartChip Real-Time qPCR System is positioned as the platform of choice for biomarker identification and validation. These biomarkers are the genetic “signatures” for the development of improved drugs and diagnostic tests, helping to make “personalized medicine” a reality.